WHO’s interim guidance “Evaluation of COVID-19 vaccine effectiveness” WHO’s interim guidance “Evaluation of COVID-19 vaccine effectiveness” Dear colleagues, Given your interest by being part of this list-serve, we thought you might be interested in the release of WHO’s interim guidance “Evaluation of COVID-19 vaccine effectiveness” which is now ava...

Plans for covid vaccine effectiveness/impact studies Dear colleagues, After COVID-19 vaccines are introduced into countries, it will be vital to generate real-world data on vaccine effectiveness and impact, as many questions will remain unanswered by the clinical trials.  Studies will likely be done in a variety of countries, in a variety of popula...

Dear Colleagues,   We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from...

Dear Colleagues,   We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia...

Dear Colleagues, We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This edition reports global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from the calendar year of 2...

Dear Colleagues,   We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from...

Acknowledgements WHO gratefully acknowledges the dedicated efforts of the numerous individuals and organizations involved with compiling this surveillance information, including Ministries of Health, sentinel hospitals, as well as the network of global, regional and national reference laboratories. WHO also gratefully acknowledges the financial sup...

(Revised version including data from Colombia which had been erroneously excluded) Dear Colleagues,  We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surve...

Dear Colleagues,  We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from ...

Dear Colleagues,  We are pleased to share the latest bulletin of the World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks. This bulletin reports the most up-to-date global surveillance data reported to WHO on pediatric diarrhea, meningitis, and pneumonia from ...

Dear Colleagues, The World Health Organization (WHO)-coordinated Global Rotavirus and Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance Networks include strong laboratories that generate high quality data to monitor disease trends over time. The IB-VPD laboratory network supports the laboratory confirmation of disease caused bySt...

Dear Colleagues, We are happy to introduce an updated WHO Surveillance Bulletin. We’ve transformed the bulletin into an electronic format, and we are changing our bi-annual reporting to April and October to reflect when surveillance data are available. The bulletin still presents a summary of case-based Invasive Bacterial Vaccine-Preventable Diseas...